Davion Healthcare Plc, a leading medical device manufacturer, has granted a Global Manufacturing and Distribution Licence for its non-invasive BreastCheck home test for Breast Anomalies including Breast Cancer, to NeuRX Health Inc, a Rhode Island (USA) based company. Under the terms of the agreement, NeuRX will pay Davion the sum of $120 Million USD for the licence, together with ongoing royalty…
No responses yet